17:02 EDT Gain Therapeutics (GANX) files $100M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Buy Rating for Gain Therapeutics: Promising Phase 1b Trial and Strong Financial Position Support Positive Outlook
- Buy Rating for Gain Therapeutics Driven by Promising Parkinson’s Program and Strong Financial Position
- Gain Therapeutics Reports Q1 2025 Financial Results
- Gain Therapeutics reports Q1 EPS (16c), consensus (18c)
- Gain Therapeutics reports preclinical data n GT-02287